tezosentan has been researched along with Cardiovascular Stroke in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gülmen, S; Kiris, I; Narin, C; Sütcü, R; Toy, H; Yilmaz, N | 1 |
| Adams, KF; Frey, A; Gattis, WA; Gheorghiade, M; Kobrin, I; O'Connor, CM; Shah, MR | 1 |
| Boomsma, F; Duncker, DJ; Houweling, B; Merkus, D; van den Meiracker, AH | 1 |
| Boomsma, F; Duncker, DJ; Houweling, B; Merkus, D; Sorop, O | 1 |
| Boomsma, F; de Beer, VJ; Dekkers, DH; Duncker, DJ; Lamers, JM; Merkus, D; Pijnappels, DA; Sorop, O | 1 |
| Clark, A; Cleland, JG; Crabbe, S; Ford, S; Houghton, T; Louis, A; Thackray, S | 1 |
| Clozel, JP; Clozel, M; Hess, P; Qiu, CB; Qiu, CS | 1 |
| Clozel, JP; Clozel, M; Hess, P; Qiu, C; Qiu, CS | 1 |
1 review(s) available for tezosentan and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
2 trial(s) available for tezosentan and Cardiovascular Stroke
| Article | Year |
|---|---|
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4).
Topics: Acute Disease; Adult; Child; Coronary Disease; Double-Blind Method; Endothelins; Female; Heart Failure; Humans; Myocardial Infarction; Pyridines; Recurrence; Syndrome; Tetrazoles; Vasodilator Agents | 2002 |
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
6 other study(ies) available for tezosentan and Cardiovascular Stroke
| Article | Year |
|---|---|
Endothelin receptor blockade with tezosentan ameliorates myocardial injury induced by abdominal aortic ischemia-reperfusion.
Topics: Abdomen; Animals; Aorta; Endothelin Receptor Antagonists; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles | 2008 |
Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction.
Topics: Animals; Arterioles; Coronary Circulation; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Female; Male; Myocardial Infarction; Oxygen; Pyridines; Sus scrofa; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2005 |
Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.
Topics: Animals; Blood Pressure; Consciousness; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Hypertension, Pulmonary; Male; Myocardial Infarction; Physical Conditioning, Animal; Pulmonary Circulation; Pyridines; Receptors, Endothelin; Rest; Swine; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2006 |
Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Hemodynamics; Irbesartan; Myocardial Infarction; Oxygen; Physical Exertion; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Tetrazoles; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation; Ventricular Function, Left; Ventricular Remodeling | 2008 |
Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Synergism; Enalapril; Endothelin Receptor Antagonists; Heart Failure; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Tetrazoles | 2001 |
Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.
Topics: Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hemodynamics; Lung; Male; Myocardial Infarction; Organ Size; Pulmonary Edema; Pyridines; Rats; Rats, Wistar; Tetrazoles; Vasodilator Agents | 2002 |